Accessibility helpSkip to navigationSkip to contentSkip to footer

Cookies on FT Sites

We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.

Accept cookies
Manage cookies
  • Sign In
  • Subscribe
Open side navigation menuOpen search bar
Financial Times
SubscribeSign InmyFT
  • Home
  • World
    Sections
    • World Home
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    • Australia & NZ
    Most Read
    • Erdoğan taps former Goldman Sachs banker to head Turkey’s central bank
    • Donald Trump says he has been indicted on federal charges in documents probe
    • Ukraine sends western tanks into battle as counter-offensive gets under way
    • Canadian wildfire smoke jars New York with ‘movie of the future’
    • Donald Trump charged with 37 counts in classified documents case
  • US
    Sections
    • US Home
    • US Economy
    • US Companies
    • US Politics & Policy
    Most Read
    • Companies
      Sections
      • Companies Home
      • Energy
      • Financials
      • Health
      • Industrials
      • Media
      • Professional Services
      • Retail & Consumer
      • Tech Sector
      • Telecoms
      • Transport
      Most Read
      • Goldman, Exane and Schroders cut ties with Odey Asset Management after assault claims
      • FCA investigates Odey Asset Management
      • Anne Boden stepped down as Starling CEO after investor clash
      • LetterOne chair Mervyn Davies receives bumper payout after Russian oligarchs’ exit
      • The Pirelli boss taking on China’s Communist party
    • Tech
    • Markets
      Sections
      • Markets Home
      • Alphaville
      • Markets Data
      • Cryptofinance
      • Capital Markets
      • Commodities
      • Currencies
      • Equities
      • Fund Management
      • Trading
      • Moral Money
      • ETF Hub
      Most Read
      • Live news updates from June 9: Trump charged with 37 counts, Boris Johnson to stand down from parliament
      • Goldman, Exane and Schroders cut ties with Odey Asset Management after assault claims
      • FCA investigates Odey Asset Management
      • Norway seeks to open vast ocean area to deep-sea mining
      • Binance US to suspend dollar transactions after payment partners pause activity
    • Climate
    • Opinion
      Sections
      • Opinion Home
      • Columnists
      • The FT View
      • Lex
      • Obituaries
      • Letters
      Most Read
      • Apple’s Vision Pro headset has made the metaverse feel outdated
      • How US cities became one big parking lot
      • Trump indictment brings him closer to the danger zone
      • Ukraine’s dam explosion is a red line: Russia must feel the consequences
      • Luxury goods: Europe’s joke on the world
    • Work & Careers
      Sections
      • Work & Careers Home
      • Business School Rankings
      • Business Education
      • Entrepreneurship
      • Recruitment
      • Business Books
      • Business Travel
      Most Read
      • Too good to be true? The fake recruiters targeting jobseekers
      • Can a virtual PA turbocharge your career?
      • Anti-monarchist Graham Smith: The British royals are ‘tax-funded Kardashians’
      • FT business books: what to read this month
    • Life & Arts
      Sections
      • Life & Arts Home
      • Arts
      • Books
      • Food & Drink
      • FT Magazine
      • House & Home
      • Style
      • Travel
      • FT Globetrotter
      Most Read
      • François Hollande: ‘Putin cannot be seduced. He respects force’
      • How Crispin Odey evaded sexual assault allegations for decades
      • Don’t blame us for AI’s threat to humanity, we’re just the technologists
      • Grand Seiko’s rock star of watchmaking
      • An Albanian adventure
    • HTSI
    MenuSearch
    • Home
    • World
    • US
    • Companies
    • Tech
    • Markets
    • Climate
    • Opinion
    • Work & Careers
    • Life & Arts
    • HTSI
    Financial Times
    SubscribeSign In

    Oxford Nanopore Technologies

    Add to myFT Digest

    Add this topic to your myFT Digest for news straight to your inbox

    • Friday, 21 April, 2023
      Investments
      Directors’ Deals: Oxford Nanopore chair boosts holding

      Company is three years away from breaking even, say analysts

    • Tuesday, 21 March, 2023
      Oxford Nanopore open to possibility of overseas listing

      UK genomic sequencing group ‘not ruling out’ any options, says chief executive

    • Monday, 8 November, 2021
      Healthcare
      Pandemic puts Oxford Nanopore ‘on the map’

      University spinout’s portable DNA sequencer has proved invaluable in tracking the global spread of coronavirus

    • Thursday, 30 September, 2021
      Oxford Nanopore shares surge more than 40 per cent in London IPO

      UK genomics group makes devices used to sequence Covid variants

    • Monday, 13 September, 2021
      Lex
      Oxford Nanopore/IPO: sequencing a would-be British success story Premium content

      Genomics company’s float should have no problems getting off the ground

    • Thursday, 9 September, 2021
      Oxford Nanopore to launch IPO in London after Covid-19 success

      Genomics company gained global prominence with role in helping track coronavirus

    • Friday, 2 July, 2021
      Oxford Nanopore to use ‘anti-takeover’ shares to remain British champion

      DNA sequencing start-up wants to avoid being bought by foreign competitor after IPO

    • Tuesday, 4 May, 2021
      Lex
      Oxford Nanopore/IPO: sequencer has Woodford in its DNA Premium content

      Investors should focus on the science, setting aside market froth

    • Tuesday, 30 March, 2021
      Oxford Nanopore picks London for latest tech IPO

      DNA sequencing group expected to be valued at £4bn to £7bn in one of largest UK floats this year

    • Friday, 11 December, 2020
      UK business & economy
      Senior England Test and Trace official joins supplier weeks after leaving post

      Emma Stanton starts at Oxford Nanopore after contract ends at government programme

    • Tuesday, 13 October, 2020
      LombardKate Burgess
      Last orders loom for big indebted pub groups

      National inn chains suffer as new lockdown policy heralds more pub closures

    • Sunday, 16 February, 2020
      News in-depthTechnology sector
      Why UK university spinouts are courting overseas investors

      There are plenty of discoveries to bring to market but domestic funding has been squeezed

    • Sunday, 7 July, 2019
      Biotech
      Oxford Nanopore opens DNA decoding kit factory

      UK biotech company hopes to challenge US dominance of gene sequencing market

    • Wednesday, 3 April, 2019
      Biotech
      Oxford Nanopore’s flotation plans are a boon for Neil Woodford

      Gene analysis group’s decision to list helps fund manager remain compliant with regulations

    • Thursday, 18 October, 2018
      Science
      Amgen invests £50m in gene-reading company Oxford Nanopore

      California-based group acquires 3 per cent stake in UK sequencing company

    • Tuesday, 20 March, 2018
      UK inward investment
      Oxford Nanopore value reaches £1.5bn as it taps Asia-Pacific funding

      Fast-growing UK biotech will build factory to meet demand for gene sequencing machines

    • Tuesday, 23 May, 2017
      LexTechnology sector
      IP Group/Touchstone: varsity match Premium content

      No laughing matter for minority investors

    • Wednesday, 5 April, 2017
      Special ReportTomorrow’s Global Business: Raising Capital
      Testing times for the UK’s university spin-off funds

      Investing in intellectual property commercialisation is not without risks

    • Monday, 12 December, 2016
      LombardJonathan Guthrie
      Sky: Gilbert must make Fox talk turkey

      Independent directors should back a scheme of arrangement for benefit of investors

    • Monday, 12 December, 2016
      UK companies
      UK biotech group raises £100m to sell DNA-reading tools in Asia

      Oxford Nanopore announces new funding from Woodford Investment and HK-based investor

    • Monday, 12 December, 2016
      Technology sector
      Oxford Nanopore announces £100m fundraising
    • Thursday, 3 November, 2016
      UK companies
      Woodford-backed UK biotech group faces new legal challenge

      Oxford Nanopore received complaint over patent infringement of two-strand DNA sequencing

    • Thursday, 4 August, 2016
      LombardInsurance
      Neil Woodford’s patient trust feeling poorly

      About 40% of WPC is in unquoted companies and two-thirds in healthcare

    • Friday, 1 April, 2016
      Pharmaceuticals sector
      Whole-genome breakthrough promises tonic for healthcare

      Accurately sequencing an individual’s DNA for less than $1,000 is now possible

    • Tuesday, 1 September, 2015
      Technology sector
      Genes genie: Oxford Nanopore’s Gordon Sanghera

      The British scientist behind a pioneering DNA sequencer is plotting its international success

    Previous page You are on page 1 Next page

    Useful links

    Support

    View Site TipsHelp CentreContact UsAbout UsAccessibilitymyFT TourCareers

    Legal & Privacy

    Terms & ConditionsPrivacy PolicyCookiesCopyrightSlavery Statement & Policies

    Services

    Share News Tips SecurelyIndividual SubscriptionsGroup SubscriptionsRepublishingExecutive Job SearchAdvertise with the FTFollow the FT on TwitterFT ChannelsFT Schools

    Tools

    PortfolioToday's Newspaper (ePaper)Alerts HubBusiness School RankingsEnterprise ToolsNews feedNewslettersCurrency Converter

    Community & Events

    FT CommunityFT Live EventsFT ForumsFT Board DirectorBoard Director Programme

    More from the FT Group

    Markets data delayed by at least 15 minutes. © THE FINANCIAL TIMES LTD 2023. FT and ‘Financial Times’ are trademarks of The Financial Times Ltd.
    The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice.
    Financial Times

    International Edition

    Subscribe for full access
    • Switch to UK Edition

    Top sections

    • Home
    • World
      • Global Economy
      • UK
      • US
      • China
      • Africa
      • Asia Pacific
      • Emerging Markets
      • Europe
      • War in Ukraine
      • Americas
      • Middle East & North Africa
      • Australia & NZ
    • US
      • US Economy
      • US Companies
      • US Politics & Policy
    • Companies
      • Energy
      • Financials
      • Health
      • Industrials
      • Media
      • Professional Services
      • Retail & Consumer
      • Tech Sector
      • Telecoms
      • Transport
    • Tech
    • Markets
      • Alphaville
      • Markets Data
      • Cryptofinance
      • Capital Markets
      • Commodities
      • Currencies
      • Equities
      • Fund Management
      • Trading
      • Moral Money
      • ETF Hub
    • Climate
    • Opinion
      • Columnists
      • The FT View
      • Lex
      • Obituaries
      • Letters
    • Work & Careers
      • Business School Rankings
      • Business Education
      • Entrepreneurship
      • Recruitment
      • Business Books
      • Business Travel
    • Life & Arts
      • Arts
      • Books
      • Food & Drink
      • FT Magazine
      • House & Home
      • Style
      • Travel
      • FT Globetrotter
    • Personal Finance
      • Property & Mortgages
      • Investments
      • Pensions
      • Tax
      • Banking & Savings
      • Advice & Comment
      • Next Act
    • HTSI
    • Special Reports

    FT recommends

    • Lex
    • Alphaville
    • Lunch with the FT
    • FT Globetrotter
    • #techAsia
    • Moral Money
    • Newsletters
    • Video
    • Podcasts
    • News feed
    • FT Live Events
    • FT Forums
    • Board Director Programme
    • myFT
    • Portfolio
    • Today's Newspaper (ePaper)
    • Crossword
    • Our Apps
    • Help Centre
    • Subscribe
    • Sign In